Company news
Lineage Cell Therapeutics, Inc. news in 2025
Lineage Cell Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Lineage Cell Therapeutics Achieves First Milestone Under Worldwide Collaboration Agreement with Genentech
November 24, 2025
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 6, 2025
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
October 30, 2025
Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
September 8, 2025
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
September 2, 2025
Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss
August 26, 2025
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
August 5, 2025
Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury
August 4, 2025
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
June 23, 2025
Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
June 5, 2025
Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
May 14, 2025
Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
May 12, 2025
Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
May 1, 2025
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
April 22, 2025
Calls in 2025
- Lineage Cell Therapeutics (NYSE American: LCTX) Q3 2025 Earnings Call
Nov 6, 2025
Transcript - Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2025 Earnings Call
Aug 12, 2025
Transcript - Lineage Cell Therapeutics (NYSE American: LCTX) Q1 2025 Earnings Call
May 13, 2025
Transcript - Lineage Cell Therapeutics (NYSE American: LCTX) Q4 2024 Earnings Call
Mar 10, 2025
Transcript
Decks in 2025
- Q1 2025 Earnings Presentation
Earnings · 38 slides · May 13, 2025
- Q4 2024 Earnings Presentation
Earnings · 43 slides · Mar 10, 2025